Home > Compound List > Compound details
175481-36-4 molecular structure
click picture or here to close

(2R)-N-benzyl-2-acetamido-3-methoxypropanamide

ChemBase ID: 72595
Molecular Formular: C13H18N2O3
Molecular Mass: 250.29362
Monoisotopic Mass: 250.13174245
SMILES and InChIs

SMILES:
C(=O)([C@@H](COC)NC(=O)C)NCc1ccccc1
Canonical SMILES:
COC[C@H](C(=O)NCc1ccccc1)NC(=O)C
InChI:
InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1
InChIKey:
VPPJLAIAVCUEMN-GFCCVEGCSA-N

Cite this record

CBID:72595 http://www.chembase.cn/molecule-72595.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(2R)-N-benzyl-2-acetamido-3-methoxypropanamide
IUPAC Traditional name
lacosamide
Synonyms
(2R)-N-benzyl-2-acetamido-3-methoxypropanamide
(R)-2-Acetamido-N-benzyl-3-methoxypropanamide
Erlosamide
Vimpat
Lacosamide
CAS Number
175481-36-4
MDL Number
MFCD08272557
PubChem SID
162037520
PubChem CID
219078

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
PubChem 219078 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 12.468967  H Acceptors 3 
H Donor 2  LogD (pH = 5.5) -0.022441661 
LogD (pH = 7.4) -0.022444889  Log P -0.022441605 
Molar Refractivity 67.5675 cm3 Polarizability 26.340395 Å3
Polar Surface Area 67.43 Å2 Rotatable Bonds 6 
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Hydrophobicity(logP)
0.392 expand Show data source
Storage Condition
-20°C expand Show data source
Target
Sodium channel expand Show data source
Purity
95% expand Show data source
95+% expand Show data source
Salt Data
Free Base expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals
Selleck Chemicals - S1253 external link
Research Area: Epilepsy, Fibromyalgia
Biological Activity:
Lacosamide is a medication developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. [1]Lacosamide is a functionalized amino acid that has activity in the maximal electroshock seizure test, like antiepileptic drugs that are believed to act through voltage-gated sodium channels. However, lacosamide does not act in a conventional way to stabilize fast sodium channel inactivation. Rather, it enhances slow inactivation.[1]Lacosamide does not affect AMPA, kainate, NMDA, GABAA, GABAB or a variety of dopaminergic, serotonergic, adrenergic, muscarinic or cannabinoid receptors and does not block potassium or calcium currents. [1]

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • http://en.wikipedia.org/wiki/Lacosamide
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle